Image_3_Clinical Outcomes and Complications of Preoperative Embolization for Intracranial Giant Meningioma Tumorectomy: A Retrospective, Observational, Matched Cohort Study.tif by Yi Yin (448434)

“…</p>Results<p>Sixty-six cases in each group were included in our study after being matched. We did not find any significant differences of estimated blood loss (600.00 (400) vs. 500.00 (500.00) ml, p = 0.31), decrease of HGB level (30.81 ± 15.82 vs. 26.59 ± 12.90 g/L, p = 0.09), gross total resection rate (74.24% vs. 77.27%, p = 0.68), surgical time (302.50 (136) vs. 300.00 (72) min, p = 0.48), blood transfusion rates (53.03% vs. 42.42%, p = 0.35), blood transfusion volume [650.00 (657.50) vs. 535.00 (875.00) ml, p = 0.63] between the embolization group and nonembolization group. …”

Image_1_Clinical Outcomes and Complications of Preoperative Embolization for Intracranial Giant Meningioma Tumorectomy: A Retrospective, Observational, Matched Cohort Study.tif by Yi Yin (448434)

“…</p>Results<p>Sixty-six cases in each group were included in our study after being matched. We did not find any significant differences of estimated blood loss (600.00 (400) vs. 500.00 (500.00) ml, p = 0.31), decrease of HGB level (30.81 ± 15.82 vs. 26.59 ± 12.90 g/L, p = 0.09), gross total resection rate (74.24% vs. 77.27%, p = 0.68), surgical time (302.50 (136) vs. 300.00 (72) min, p = 0.48), blood transfusion rates (53.03% vs. 42.42%, p = 0.35), blood transfusion volume [650.00 (657.50) vs. 535.00 (875.00) ml, p = 0.63] between the embolization group and nonembolization group. …”

Image_2_Clinical Outcomes and Complications of Preoperative Embolization for Intracranial Giant Meningioma Tumorectomy: A Retrospective, Observational, Matched Cohort Study.tif by Yi Yin (448434)

“…</p>Results<p>Sixty-six cases in each group were included in our study after being matched. We did not find any significant differences of estimated blood loss (600.00 (400) vs. 500.00 (500.00) ml, p = 0.31), decrease of HGB level (30.81 ± 15.82 vs. 26.59 ± 12.90 g/L, p = 0.09), gross total resection rate (74.24% vs. 77.27%, p = 0.68), surgical time (302.50 (136) vs. 300.00 (72) min, p = 0.48), blood transfusion rates (53.03% vs. 42.42%, p = 0.35), blood transfusion volume [650.00 (657.50) vs. 535.00 (875.00) ml, p = 0.63] between the embolization group and nonembolization group. …”

Table_1_Clinical Outcomes and Complications of Preoperative Embolization for Intracranial Giant Meningioma Tumorectomy: A Retrospective, Observational, Matched Cohort Study.docx by Yi Yin (448434)

“…</p>Results<p>Sixty-six cases in each group were included in our study after being matched. We did not find any significant differences of estimated blood loss (600.00 (400) vs. 500.00 (500.00) ml, p = 0.31), decrease of HGB level (30.81 ± 15.82 vs. 26.59 ± 12.90 g/L, p = 0.09), gross total resection rate (74.24% vs. 77.27%, p = 0.68), surgical time (302.50 (136) vs. 300.00 (72) min, p = 0.48), blood transfusion rates (53.03% vs. 42.42%, p = 0.35), blood transfusion volume [650.00 (657.50) vs. 535.00 (875.00) ml, p = 0.63] between the embolization group and nonembolization group. …”

VisAccel complete data_redacted2.xlsx by Miguel A. Yakouma (21439852)

“…When the velocity profile of the visual stimulus matched the velocity profile of inertial motion, the inertial stimulus was biased 10.0 ± 1.8° (mean ± SE) with a 45° visual offset, 8.9 ± 1.7° with a 60° offset, and 9.3° ± 2.5 ± with a 75° offset. …”

Supplementary Material for: A Systematic Review and Meta-Analysis of Molecular Biomarkers Associated with Early Neurological Deterioration Following Acute Stroke by Martin A.J. (6051545)

“…After classification into 3 broad categories, meta-analysis showed that biomarkers associated with increased END risk (n; fixed-effects mean difference; 95% CI) were “metabolic” (glucose [<i>n</i> = 9,481; 0.90 mmol/L; 0.74–1.06], glycosylated haemoglobin [<i>n</i> = 3,146; 0.33%; 0.19–0.46], low-density lipoprotein [<i>n</i> = 4,839; 0.13 mmol/L; 0.06–0.21], total cholesterol [<i>n</i> = 4,762; 0.21 mmol/L; 0.11–0.31], triglycerides [<i>n</i> = 4,820; 0.11 mmol/L; 0.06–0.17], urea [<i>n</i> = 1,351; 0.55 mmol/L; 0.14–0.96], decreasing albumin [<i>n</i> = 513; 0.33 g/dL; 0.05–0.61]); “inflammatory and excitotoxic” (plasma glutamate [<i>n</i> = 688; 60.13 µmol/L; 50.04–70.22], CSF glutamate [<i>n</i> = 369; 7.50 µmol/L; 6.76–8.23], homocysteine [<i>n</i> = 824; 2.15 µmol/L; 0.68–3.61], leucocytes [<i>n</i> = 3,766; 0.54 × 10⁹/L; 0.34–0.74], high-sensitivity C-reactive protein [<i>n</i> = 1,707; 3.79 mg/L; 1.23–6.35]); and “coagulation/haematological” (fibrinogen [<i>n</i> = 3,132; 0.32 g/L; 0.25–0.40]; decreasing haemoglobin [<i>n</i> = 3,586; 2.38 g/L; 0.15–4.60]). …”

Fig 7 - by Rajnish Prakash Singh (2847608)

Fig 6 - by Rajnish Prakash Singh (2847608)

Unequal effects of intramammary rapamycin administration on milk protein gene expression in individual calves. by Anna Kosenko (12908417)

DataSheet_1_Case report: A patient with brachio-cervical inflammatory myopathy was misdiagnosed as flail arm syndrome.docx by Hui Sun (107933)

Table_2_Effectiveness and tolerability of different therapies in preventive treatment of MOG-IgG-associated disorder: A network meta-analysis.docx by Xiaofei Wang (135107)

“…AZA, MMF, OC and RTX showed a trend to decrease ARR, but those results did not reach significant differences. …”

Table_1_Effectiveness and tolerability of different therapies in preventive treatment of MOG-IgG-associated disorder: A network meta-analysis.docx by Xiaofei Wang (135107)

“…AZA, MMF, OC and RTX showed a trend to decrease ARR, but those results did not reach significant differences. …”

Table_6_Effectiveness and tolerability of different therapies in preventive treatment of MOG-IgG-associated disorder: A network meta-analysis.xlsx by Xiaofei Wang (135107)

“…AZA, MMF, OC and RTX showed a trend to decrease ARR, but those results did not reach significant differences. …”

Table_3_Effectiveness and tolerability of different therapies in preventive treatment of MOG-IgG-associated disorder: A network meta-analysis.docx by Xiaofei Wang (135107)

“…AZA, MMF, OC and RTX showed a trend to decrease ARR, but those results did not reach significant differences. …”

Table_4_Effectiveness and tolerability of different therapies in preventive treatment of MOG-IgG-associated disorder: A network meta-analysis.docx by Xiaofei Wang (135107)

“…AZA, MMF, OC and RTX showed a trend to decrease ARR, but those results did not reach significant differences. …”

The effect of <i>t</i>-BHQ treatment on metal transcriptional factor-1 (MTF-1) mRNA expression. by Takumi Ishida (149778)

Dose-dependent alteration in heme oxygenase-1 mRNA expression following <i>t</i>-BHQ treatment. by Takumi Ishida (149778)

Table1_Reduction in broad-spectrum antimicrobial prescriptions by primary care pediatricians following a multifaceted antimicrobial stewardship program.docx by F Pagano (14336988)

“…The prescription rates of Amoxicillin-Clavulanate (50.25 to 14.21; R²= 0.983, p = 0.001) and third generation Cephalosporins (28.43 to 5.43; R²= 0.995, p < 0.01) significantly decreased; we didn't find significant modifications in the prescription rates of Amoxicillin and Quinolones; finally, we observed a trend toward reduction in the prescription of Macrolides. …”

Supplementary Material for: Efficacy and safety of finerenone in Asian patients with type 2 diabetes and chronic kidney disease: A FIDELITY analysis by figshare admin karger (2628495)

“…Methods For this subanalysis, efficacy outcomes included a CV composite (time to CV death, non-fatal myocardial infarction, non-fatal stroke or hospitalization for heart failure) and kidney composite (kidney failure, sustained ≥57% estimated glomerular filtration rate [eGFR] decrease from baseline over ≥4 weeks or renal death) outcome. …”

Supplementary file 1_Exposure-response analyses of venetoclax combined with hypomethylating agents in myelodysplastic syndromes: a retrospective study.docx by Ji-Xin Tian (21710993)

“…Compared to VEN 400 mg administered without azole antifungals, concomitant use of azole antifungals with VEN 100 mg resulted in a 100.03% and 18.50% increase in VEN C₀ and C₆, respectively. …”